Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias

BMC Cancer

Volumn 12, Issue , 2012, Pages

  López Cima, M F ^a,b   Álvarez Avellón, Sara M ^a,b   Pascual, Teresa ^c   Fernández Somoano, Ana ^a,b   Tardón, Adonina ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

Author keywords

CYP1A1; GSTM1; GSTP1; GSTT1; Lung cancer; Metabolic genes; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYP1A1 GENE; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPING TECHNIQUE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; ONCOGENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONS; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; SPAIN;

EID: 84870812290     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-433     Document Type: Article

References (61)

1. Levi F. Cancer prevention: epidemiology and perspectives. Eur J Cancer 1999, 35:1046-1058. 10.1016/S0959-8049(99)00094-5, 10533447.
2. Spitz MR, Wu X, Wilkinson A, Wei Q. Cancer of the lung. Cancer Epidemiology and Prevention. Third Edition 2006, 638-658. Oxford University Press, New York, Schottenfeld D, Fraumeni JF Jr.
3. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008, 29(6):1164-1169. 10.1093/carcin/bgn020, 18258609.
4. Skuladottir H, Autrup H, Autrup J, Tjoenneland A, Overvad K, Ryberg D, Haugen A, Olsen JH. Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer 2005, 48:187-199. 10.1016/j.lungcan.2004.10.013, 15829318.
5. Reszka E, Wasowicz W. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk. Int J Occup Med Environ Health 2001, 14:99-113.
6. Hong JY, Yang CS. Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity. Environ Health Perspect 1997, 105(Suppl 4):759-762. 10.1289/ehp.97105s4759, 1470024, 9255558.
7. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem (Tokyo) 1991, 110:407-411.
8. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 1991, 19:4797. 328759, 1891387.
9. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000, 9:3-28.
10. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, Min S, Lan Q, Marchand Le L, Lin P, Lung ML, Pinarbasi H, Pisani P, Srivatanakul P, Seow A, Sugimura H, Tokudome S, Yokota J, Taioli E. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 2008, 17:1120-1126. 10.1158/1055-9965.EPI-07-2786, 18463401.
11. Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Marchand Le L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L, Taioli E. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003, 104:650-657. 10.1002/ijc.10995, 12594823.
12. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995, 30:445-600. 10.3109/10409239509083491, 8770536.
13. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000, 463:247-283. 10.1016/S1383-5742(00)00050-8, 11018744.
14. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88. 10.1146/annurev.pharmtox.45.120403.095857, 15822171.
15. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001, 10:1239-1248.
16. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997, 6:733-743.
17. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmoller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Ingelman-Sundberg M, Kalina I, Kihara M, Kremers P, Marchand Le L, London SJ, Nazar-Stewart V, Onon-Kihara M, Rannug A, Romkes M, Ryberg D, Seidegard J, Shields P, Strange RC, Stucker I, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002, 23:1343-1350. 10.1093/carcin/23.8.1343, 12151353.
18. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M, Schneider J, Seow A, Shields PG, Sobti RC, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006, 164:1027-1042. 10.1093/aje/kwj321, 17000715.
19. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006, 3:e91. 10.1371/journal.pmed.0030091, 1391981, 16509765.
20. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998, 19:275-280. 10.1093/carcin/19.2.275, 9498276.
21. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997, 272:10004-10012. 10.1074/jbc.272.15.10004, 9092542.
22. Hu X, Ji X, Srivastava SK, Xia H, Awasthi S, Nanduri B, Awasthi YC, Zimniak P, Singh SV. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 1997, 345:32-38. 10.1006/abbi.1997.0269, 9281308.
23. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernström B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998, 19:433-436. 10.1093/carcin/19.3.433, 9525277.
24. Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis 2005, 26:811-819. 10.1093/carcin/bgi023, 15661806.
25. Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, Butkiewicz D, Fong KM, Gené M, Hirvonen A, Kiyohara C, Larsen JE, Lin P, Raaschou-Nielsen O, Povey AC, Reszka E, Risch A, Schneider J, Schwartz AG, Sorensen M, To-Figueras J, Tokudome S, Pu Y, Yang P, Wenzlaff AS, Wikman H, Taioli E. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2009, 169:802-814. 10.1093/aje/kwn417, 2727222, 19240225.
26. Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 2004, 208:65-74. 10.1016/j.canlet.2004.01.002, 15105047.
27. Sorensen M, Raaschou-Nielsen O, Brasch-Andersen C, Tjonneland A, Overvad K, Autrup H. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2007, 55:137-144. 10.1016/j.lungcan.2006.10.010, 17123660.
28. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005, 26(12):2207-2212. 10.1093/carcin/bgi191, 16051642.
29. Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S, Hirvonen A. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 1998, 8:495-502. 10.1097/00008571-199812000-00006, 9918133.
30. Honma HN, De Capitani EM, Perroud MW, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L. Influence of p53 codon 72 exon4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 2008, 61(2):152-162. 10.1016/j.lungcan.2007.12.014, 18280004.
31. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, Vainio H, Husgafvel-Pursiainen K, Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998, 77(4):516-521. 10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X, 9679751.
32. Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions. Biomarkers 2004, 9:298-305. 10.1080/13547500400011070, 15764294.
33. Fernandez-Rubio A, Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Tardon A. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. Lung Cancer 2008, 61:309-316. 10.1016/j.lungcan.2008.01.017, 18336951.
34. Gonzalez-Arriaga P, Lopez-Cima MF, Fernandez-Somoano A, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk. BMC Cancer 2008, 8:378. 10.1186/1471-2407-8-378, 2628929, 19094243.
35. Leader A, Fernandez-Somoano A, Lopez-Cima MF, Gonzalez-Arriaga P, Pascual T, Marron MG, Tardon A. Educational inequalities in quantity, duration and type of tobacco consumption among lung cancer patients in Asturias: epidemiological analyses. Psicothema 2010, 22:634-640.
36. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain. BMC Cancer 2007, 7:162. 10.1186/1471-2407-7-162, 2020474, 17705814.
37. Marin MS, Lopez-Cima MF, Garcia-Castro L, Pascual T, Marron MG, Tardon A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004, 13:1788-1793.
38. Office of Federal Statistical Policy and Standards Standard occupational classification manual 1977, US Government Printing Office, Washington, DC, Office of Federal Statistical Policy and Standards.
39. Office of Federal Statistical Policy and Standards Standard industrial classification manual 1972, US Government Printing Office, Washington, DC, Office of Federal Statistical Policy and Standards.
40. International Agency for Research on Cancer IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2012, Lyon, http://monographs.iarc.fr/ENG/Classification/index.php. Accessed May 3, 2012, International Agency for Research on Cancer.
41. Simonato L, Saracci R. Cancer, occupational. International Labor Organization (ILO). Encyclopedia of Occupational Safety and Health 1983, 369-375. ILO, Geneva.
42. Siemiatycki J, Richardson L, Boffetta P. Occupation. Cancer Epidemiology and Prevention 2006, 322-354. Oxford University Press, New York, Schottenfeld D, Fraumeni JF, Third.
43. De Matteis S, Consonni D, Bertazzi PA. Exposure to occupational carcinogensand lung cancer risk. Evolution of epidemiological estimates of attributable fraction. Acta Biomed 2008, 79(suppl 1):34-42.
44. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S, Rousseau MC, Boffetta P. Listing occupational carcinogens. Environ Health Perspect 2004, 112(15):1447-1459. 10.1289/ehp.7047, 1247606, 15531427.
45. Ahrens W, Merletti F. A standard tool for the analysis of occupational lung cancer in epidemiologic studies. Int J Occup Environ Health 1998, 4(4):236-240.
46. Mirabelli D, Chiusolo M, Calisti R, Massacesi S, Richiardi L, Nesti M, Merletti F. Database of occupations and industrial activities that involve the risk of pulmonary tumors (in Italian). Epidemiol Prev 2001, 25(4-5):215-221.
47. Consonni D, De Matteis S, Lubin JH, Wacholder S, Tucker M, Pesatori AC, Caporaso NE, Bertazzi PA, Landi MT. Lung cancer and occupation in a population-based case-control study. Am J Epidemiol 2010, 171:323-333. 10.1093/aje/kwp391, 2808498, 20047975.
48. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
49. Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS. The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:1485-1488.
50. Ng DP, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 2005, 16:399-405. 10.1007/s10552-004-5476-0, 15953982.
51. Wang Y, Spitz MR, Schabath MB, Ali-Osman F, Mata H, Wu X. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer 2003, 40:25-32. 10.1016/S0169-5002(02)00537-8, 12660004.
52. Wolf FM. Meta-analysis: quantitative methods for research synthesis 1986, Sage Publications, Beverly Hills.
53. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, Leoni VP, Le Marchand L, London SJ, Neri M, Povey AC, Rannug A, Reszka E, Ryberg D, Risch A, Romkes M, Ruano-Ravina A, Schoket B, Spinola M, Sugimura H, Wu X, et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res 2005, 592:45-57. 10.1016/j.mrfmmm.2005.06.002, 16009381.
54. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 2006, 27:525-532.
55. Brockmöller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Pharmacogenetics 1996, 6:535-545. 10.1097/00008571-199612000-00007, 9014203.
56. Golka K, Hermes M, Selinski S, Blaszkewicz M, Bolt HM, Roth G, Dietrich H, Prager HM, Ickstadt K, Hengstler JG. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet Genomics 2009, 19:903-906. 10.1097/FPC.0b013e328331b554, 19801959.
57. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, di CA S, Porru S. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004, 110:598-604. 10.1002/ijc.20157, 15122594.
58. Ma QW, Lin GF, Chen JG, Shen JH. Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 2002, 15:253-260.
59. Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 2003, 40:247-258. 10.1016/S0169-5002(03)00076-X, 12781423.
60. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B, Bartsch H. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001, 11:757-764. 10.1097/00008571-200112000-00003, 11740339.
61. Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 2001, 33:133-141. 10.1016/S0169-5002(01)00182-9, 11551408.